drugset / Trial / NCT00596037

Treatment of Adults With Growth Hormone Deficiency

NCT00596037 ↗

Phase 3 Completed 136 enrolled LG Life Sciences BioPartners GmbH · collab
RandomizedSingle-groupOpen-labelTreatment

Summary

The objective of this rollover study is to evaluate the long term (1 year) safety of a new weekly administered growth hormone preparation in adults with growth hormone deficiency who were treated with the same experimental preparation in study BPLG-005. In addition, further change in efficacy endpoints of BPLG-005 by prolonged treatment will be evaluated. Additional efficacy and safety data of the experimental preparation will be obtained from the switch-over patients.

Timeline

Start
2006-08
Primary completion
2008-09
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject LB03002 Protein / enzyme biologic — —